Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROPINE study
2012-004326-16Phase 3Active
- Sponsor
- Ospedale Pediatrico Bambino Gesù
- Start
- Nov 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of prednisone in Idiopathic nephrotic syndrome (INS) (2 arms), sponsored by Ospedale Pediatrico Bambino Gesù. Primary endpoints: Proportion of patients in remission at 6 months after treatment and Relative toxicity of prednisone in the two protocols. Started Nov 2012; status: active.
02
Drugs
prednisone
03
Conditions
Idiopathic nephrotic syndrome (INS)
Beyond the preview
Go deeper on 2012-004326-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004326-16.